RE-BVS – Piemonte Repository

Sfoglia per AUTORE
AGLIETTA M
Collezione ASL VCO

Items : 6

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. in Gynecologic oncology / Gynecol Oncol. 2021 Jul;162(1):80-87. doi: 10.1016/j.ygyno.2021.04.018. Epub 2021 Apr 22.

2021
ASL VCO
AO Ordine Mauriziano

Valabrega G; Aglietta M; Pasini B; Di Maio M; Zavallone L; Gemmiti S; Turinetto M; Mittica G; Ghisoni E; Villa M; Tuninetti V; Mangiacotti S; Cosma S; Ferrero A; Borella F; Farolfi A; Katsaros D; De Giorgi U; Scotto G; Giannone G;

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers. in Journal of ovarian research / J Ovarian Res. 2020 May 4;13(1):53. doi: 10.1186/s13048-020-00655-2.

2020
ASL VCO

Mittica G; Goia M; Gambino A; Scotto G; Fonte M; Senetta R; Aglietta M; Borella F; Sapino A; Katsaros D; Maggiorotto F; Ghisoni E; Giannone G; Tuninetti V; Genta S; Eusebi C; Momi M; Cassoni P; Valabrega G;

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer. in Scientific reports / Sci Rep. 2020 Apr 15;10(1):6478. doi: 10.1038/s41598-020-63634-z.

2020
ASL VCO

Capellero S; Erriquez J; Melano C; Mesiano G; Genta S; Pisacane A; Mittica G; Ghisoni E; Olivero M; Di Renzo MF; Aglietta M; Sangiolo D; Valabrega G;

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan. in Clinical colorectal cancer / Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.

2019
ASL Biella
ASL VCO
AO Ordine Mauriziano

Vasile E; Aglietta M; Meurisse A; Buscaglia P; Passardi A; Clerico M; Pasquini G; Neuzillet C; Falcone A; Edeline J; Spadi R; Satolli MA; Sperti E; Musettini G; De Luca E; Vernerey D; Lombardi P; Vivaldi C; Lièvre A; Casadei-Gardini A; Brac C; Vienot A; Leone F; Fornaro L; Montagnani F;

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study. in Cancer medicine / Cancer Med. 2018 Sep;7(9):4339-4344. doi: 10.1002/cam4.1687. Epub 2018 Jul 20.

2018
ASL Asti
ASL VCO

Tealdi G; Parola G; Bertola G; Grasso B; Volpone C; Calori A; Solinas G; Berchialla P; Longo V; Foresto M; Cagnazzo C; Martinello R; Geuna E; Milani A; Galizia D; Giuliano PL; Ballari AM; Aglietta M; Montemurro F;

Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer. in JAMA oncology / JAMA Oncol. 2016 Apr;2(4):445-52. doi: 10.1001/jamaoncol.2015.4720.

2016
ASL Asti
ASL VCO

Tealdi G; Parola G; Volpone C; Bertola G; Grasso B; Calori A; Gallizioli S; Foresto M; Culotta P; Martinello R; Solinas G; Berchialla P; Longo V; Cagnazzo C; Mittica G; Montemurro F; Giuliano PL; Aglietta M; Ballari AM;